News
With a demand that vaccine boosters be tested against placebos, RFK Jr. puts an old antivaccine claim at the forefront of government health policy.
Momentum is building to scale back the current recommendation that all children over 6 months old get immunized against the ...
CRISPR Therapeutics faces challenges with a 20% stock drop, slow Casgevy commercialization, and regulatory hurdles. Read more ...
In his new role with the FDA, Dr. Vinay Prasad will oversee the regulation of costly drugs, including vaccines, gene ...
The UCSF professor and frequent YouTube poster has criticized COVID-19 vaccine mandates as well as the accelerated approval ...
WASHINGTON — In his first address to FDA staff on Wednesday, Vinay Prasad emphasized his commitment to evidence, his ...
The appointment, announced May 6 by FDA Commissioner Dr. Marty Makary, places Prasad at the helm of one of the agency’s most ...
16hon MSN
Find insight on Trulieve Cannabis, Novo Nordisk, Siemens Healthineers, Fresenius and more in the latest Market Talks covering ...
The FDA's decision to appoint Vinay Prasad, MD, MPH, to head its Center for Biologics Evaluation and Research (CBER) raised ...
16h
Investor's Business Daily on MSNThe 'Double Whammy' That Sent Sarepta Stock To An Eight-Year LowSarepta stock plummeted Wednesday on a "double whammy" that includes its trimmed 2025 sales outlook and a critical Food and ...
The U.S. Food and Drug Administration (FDA) has chosen Dr. Vinay Prasad, a professor at the University of California-San ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results